Medscape
TOPLINE: Over one third of patients with giant cell arteritis exhibit vascular inflammation even after receiving treatment with tocilizumab and glucocorticoids for at least 6 months, which suggests the need for more effective anti-inflammatory strategies. METHODOLOGY: Researchers conducted a retrospective cohort study to evaluate the effects of tocilizumab and glucocorticoid treatment on histopathologic changes in …
Read More
Inflammation Often Remains Following Tocilizumab Use for GCA
Elroy Schewe
17:20
TOPLINE: Over one third of patients with giant cell arteritis exhibit vascular inflammation even after receiving treatment with tocilizumab and glucocorticoids for at least 6 months, which suggests the need for more effective anti-inflammatory strategies. METHODOLOGY: Researchers conducted a retrospective cohort study to evaluate the effects of tocilizumab and glucocorticoid treatment on histopathologic changes in